Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target ; volume:41 ; number:1 ; day:2 ; month:5 ; year:2022 ; pages:1-19 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (2.5.2022), 1-19, 12.2022
- Urheber
-
Qie, Shuo
Sang, Nianli
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02370-w
- URN
-
urn:nbn:de:101:1-2022071021514928866760
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qie, Shuo
- Sang, Nianli
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumour macrophages as potential targets of bisphosphonates
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
Circular RNA in Retina: A Potential Biomarker and Therapeutic Target
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Small Dense Low-Density Lipoprotein: Biomarker or Potential Drug Target?
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
Tumour macrophages as potential targets of bisphosphonates
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
Circular RNA in Retina: A Potential Biomarker and Therapeutic Target
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Small Dense Low-Density Lipoprotein: Biomarker or Potential Drug Target?
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
Tumour macrophages as potential targets of bisphosphonates
CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
MIA is a potential biomarker for tumour load in neurofibromatosis type 1
Circular RNA in Retina: A Potential Biomarker and Therapeutic Target
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Small Dense Low-Density Lipoprotein: Biomarker or Potential Drug Target?
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Glutamine metabolism as a potential biomarker and target for cancer radiosensitization
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer